Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2022
Our Purpose
What we do
The sustainable improvement of animal health and welfare globally
Our Approach to ESG
Our new ESG strategy is based on our Purpose and Values.
We have chosen to support the United Nations Sustainable Development Goals (SDGs).
Our Strategy
How we achieve our Purpose
Strategic Growth Drivers
Pipeline
Delivery
Portfolio
Focus
Geographical
Expansion
Acquisition
Strategic Enablers
Manufacturing & Supply Chain
Technology
People
ESG
Our Structure
EU Pharmaceuticals
Dechra Veterinary Products EU (DVP EU)
Markets and sells Dechra's products in 19 countries. The key products are predominately CAP, Equine and FAP. DVP EU markets a range of specialist, therapeutic pet diets, branded Specific.
Dechra Veterinary Products International (DVP International)
Markets and sells Dechra's veterinary products in Australia, New Zealand, and Brazil through our own legal entities and via distributors to countries worldwide (including Eastern Europe). DVP ANZ manufactures, markets and sells branded non-proprietary prescription and other related companion animal products. DVP Brazil predominately manufactures, markets and sells vaccines in Brazil, other South American markets and some Asian countries.
Dechra Pharmaceuticals Manufacturing and Supply (DPM&S)
Manufactures and supplies Dechra’s product range efficiently to the highest quality standards maintaining a reliable supply chain. Approximately 40% of Dechra’s pharmaceuticals are produced within our own manufacturing sites with the remaining 60% managed through external supply relationships.
North America Pharmaceutical
Dechra Veterinary Products NA (DVP NA)
Markets and sells Dechra's veterinary products in Canada, Mexico and the US. DVP US and Canada currently market CAP and Equine medicines. DVP Mexico markets CAP, FAP and Equine medicines, mainly in Mexico and also exports to Central America countries.
Product Development and Regulatory Affairs (PDRA)
Develops Dechra's own branded veterinary product portfolio of novel, generic and generic plus pharmaceuticals and related medical products. It obtains licences for our products, manages post approval adverse event reporting, periodic product renewals and other activities required to maintain the product licences.
Our Products
Our products can be divided into four categories. All are targeted at providing veterinary professionals with solutions for their customers’ needs.
Companion Animal Products (CAP)
Species: Dogs and cats.
Key Therapeutic Sectors: endocrinology, dermatology, analgesia and anaesthesia, cardiovascular and critical care.
Percentage of Revenue
Food Producing Animal Products (FAP)
Species: Poultry, pigs and an increasing presence in cattle.
Key Therapeutic Sectors: water soluble antibiotics, vaccines, the treatment of mastitis, lameness and pain management.
Percentage of Revenue
Equine
Species: Horses and ponies.
Key Therapeutic Sectors: locomotion (lameness) and pain
management.
Percentage of Revenue
Nutrition
Species: Dogs and cats.
Key Therapeutic Sectors: Our pet diets are available to support the wellbeing of animals with numerous therapeutic conditions.
Percentage of Revenue
Our Global Footprint
We currently have sales and marketing organisations in 25 countries and market our products in 63 other countries worldwide through distributors or marketing partners.
World Map
Manufacturing Sites
Distribution Centres
Dechra Sales and Marketing
Distribution Partners
Key to Map
Dechra Sales and Marketing Countries
Distribution Partners
Dechra Distribution Centres
Dechra Manufacturing Sites
North America
Dechra Veterinary Products markets and sells Dechra’s products via its own sales and marketing organisations or via distributors in Canada, Mexico and the USA, the latter being the world’s largest animal health market. In addition, there are manufacturing sites in Florida and Texas. Product Development and Regulatory Affairs teams are also located in the three countries.
Major Geographies: United States
Percentage of Revenue
Europe
Dechra Veterinary Products markets and sells Dechra’s products in 39 countries either via its own sales and marketing organisations or via distributors. Its main distribution centre is in Denmark. There are manufacturing sites and Product Development and Regulatory Affairs teams in Croatia, the Netherlands and the UK
Major Geographies: France, Germany,the Netherlands and the UK
Percentage of Revenue
Rest of the World
Dechra Veterinary Products markets and sells Dechra’s products in 39 countries either via its sales and marketing organisations (Australia, New Zealand (ANZ) and Brazil) or via distributors. Dechra has manufacturing facilities and a Product Development and Regulatory Affairs presence in Australia and Brazil.
Major Geographies: Australia, New Zealand, Asia and Brazil
Percentage of Revenue
